ResMed Inc (RMD)
Receivables turnover
| Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 5,146,330 | 5,021,540 | 4,926,780 | 4,807,490 | 4,546,017 | 4,444,877 | 4,364,797 | 4,235,737 | 4,222,994 | 4,015,671 | 3,763,271 | 3,624,405 | 3,578,126 | 3,539,492 | 3,443,759 | 3,348,896 | 3,196,825 | 3,091,065 | 3,091,753 | 3,027,899 |
| Receivables | US$ in thousands | 939,492 | 939,516 | 959,753 | 811,198 | 837,275 | 779,265 | 729,740 | 692,388 | 704,909 | 686,264 | 672,271 | 620,483 | 575,950 | 508,580 | 526,036 | 575,554 | 614,292 | 525,014 | 509,364 | 464,892 |
| Receivables turnover | 5.48 | 5.34 | 5.13 | 5.93 | 5.43 | 5.70 | 5.98 | 6.12 | 5.99 | 5.85 | 5.60 | 5.84 | 6.21 | 6.96 | 6.55 | 5.82 | 5.20 | 5.89 | 6.07 | 6.51 |
June 30, 2025 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $5,146,330K ÷ $939,492K
= 5.48
The receivables turnover ratio for ResMed Inc. exhibits notable fluctuations over the period from September 2020 to June 2025. Starting at 6.51 times in September 2020, the ratio experienced a decline reaching a low point of approximately 5.20 times in June 2021, indicating a period where the company was collecting receivables somewhat more slowly compared to prior periods.
Following this trough, a recovery is observed, with the ratio rising to 6.55 times in December 2021 and peaking at 6.96 times in March 2022. These increases suggest improved efficiency in collecting accounts receivable during this interval. After the peak in early 2022, the ratio declines slightly to 6.21 times in June 2022 and then further down to 5.84 times by September 2022, indicating a modest slowdown in collection efficiency.
Subsequent data points reveal slight volatility: the ratio decreases to approximately 5.60 times at the end of 2022, then gently rises to around 5.99 in June 2023 and 6.12 in September 2023, reflecting periods of incremental improvement. The ratio dips again to about 5.13 in December 2024 before increasing slightly to 5.48 in June 2025.
Throughout the analyzed period, the receivables turnover ratio demonstrates cyclical movements, with notable peaks in early 2022 and gradual declines thereafter. Despite fluctuations, the ratio generally appears to hover within a range of approximately 5.13 to 6.96 times, indicating a relatively stable receivables collection efficiency with periods of improvement and slowdown. The overall trend suggests that ResMed Inc. manages its accounts receivable with a moderate level of efficiency, periodically enhancing or slightly reducing collection performance across fiscal periods.
Peer comparison
Jun 30, 2025